Ifenprodil COVID-19 Updates with Algernon CEO Christopher Moreau

 

Christopher J. Moreau, CEO, Algernon Pharmaceuticals live on Facebook to update investors on our multinational Phase 2b/3 trial of Ifenprodil.

The event was held on October 2nd at 2 PM ET.

Share via
Copy link
Powered by Social Snap